Patents by Inventor Bichismita Sahu

Bichismita Sahu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11279736
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: March 22, 2022
    Assignee: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Patent number: 11084784
    Abstract: The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparation. The invention further relates to pharmaceutical compositions containing the compounds and their use in the treatment of diseases or disorders mediated by ROR?.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: August 10, 2021
    Assignee: PIRAMAL ENTERPRISES LIMITED
    Inventors: Rajiv Sharma, Bichismita Sahu, Sunil Vasantrao Mali, Deepak Singh, Pramod Bhaskar Kumar, Mahesh Dawange, Hitesh Mistry
  • Publication number: 20210214397
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Application
    Filed: August 26, 2020
    Publication date: July 15, 2021
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. LY, Srinivas RAPIREDDY, Bichismita SAHU
  • Patent number: 10793605
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: October 6, 2020
    Assignee: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Publication number: 20190292227
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Patent number: 10364272
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: July 30, 2019
    Assignee: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Publication number: 20190062378
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Application
    Filed: September 27, 2018
    Publication date: February 28, 2019
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Patent number: 10160787
    Abstract: Described are ?-PNA monomers, methodology for synthesizing them, and methodology for synthesizing PNA oligomers that incorporate them.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 25, 2018
    Assignee: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Publication number: 20180291065
    Abstract: Described are ?-PNA monomers, methodology for synthesizing them, and methodology for synthesizing PNA oligomers that incorporate them.
    Type: Application
    Filed: May 7, 2018
    Publication date: October 11, 2018
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. LY, Srinivas RAPIREDDY, Bichismita SAHU
  • Patent number: 10093700
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: October 9, 2018
    Assignee: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Publication number: 20180215707
    Abstract: The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparation. The invention further relates to pharmaceutical compositions containing the compounds and their use in the treatment of diseases or disorders mediated by ROR?.
    Type: Application
    Filed: March 25, 2015
    Publication date: August 2, 2018
    Applicant: Piramal Enterprises Limited
    Inventors: Rajiv SHARMA, Bichismita SAHU, Sunil Vasantrao MALI, Deepak SINGH
  • Publication number: 20160096867
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Application
    Filed: October 23, 2015
    Publication date: April 7, 2016
    Applicant: CARNEGIE MELLON UNIVERSITY CENTER FOR TECHNOLOGY TRANSFER & ENTERPRISE
    Inventors: Danith H. LY, Srinivas RAPIREDDY, Bichismita SAHU
  • Patent number: 9193758
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: November 24, 2015
    Assignee: Carnegie Mellon University Center for Technology Transfer & Enterprise
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Patent number: 9062046
    Abstract: The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.
    Type: Grant
    Filed: July 15, 2011
    Date of Patent: June 23, 2015
    Assignee: Piramal Enterprises Limited
    Inventors: Sanjay Kumar, Rajiv Sharma, Robert Zahler, Bichismita Sahu, Veena R. Agarwal, Nishigandha Naik
  • Publication number: 20140128570
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Application
    Filed: April 6, 2012
    Publication date: May 8, 2014
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Publication number: 20130116248
    Abstract: The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.
    Type: Application
    Filed: July 15, 2011
    Publication date: May 9, 2013
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Sanjay Kumar, Rajiv Sharma, Robert Zahler, Bichismita Sahu, Veena R. Agarwal, Nishigandha Naik